11843248

Source:http://linkedlifedata.com/resource/pubmed/id/11843248

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008838, umls-concept:C0015133, umls-concept:C0087111, umls-concept:C0332174, umls-concept:C0442027, umls-concept:C0677886
pubmed:issue	12
pubmed:dateCreated	2002-2-14
pubmed:abstractText	Response rates to chemotherapy in relapsed, platinum resistant epithelial ovarian cancer remain poor. We have explored the effectiveness of weekly cisplatin combined with prolonged oral etoposide in this patient group.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/9007735
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cisplatin, http://linkedlifedata.com/resource/pubmed/chemical/Etoposide
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	0923-7534
pubmed:author	pubmed-author:MahmoudiMM, pubmed-author:MeyerTT, pubmed-author:NelstropA EAE, pubmed-author:RustinG JGJ
pubmed:issnType	Print
pubmed:volume	12
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1705-9
pubmed:dateRevised	2006-4-24
pubmed:meshHeading	pubmed-meshheading:11843248-Adenocarcinoma, Clear Cell, pubmed-meshheading:11843248-Adenocarcinoma, Mucinous, pubmed-meshheading:11843248-Administration, Oral, pubmed-meshheading:11843248-Adult, pubmed-meshheading:11843248-Aged, pubmed-meshheading:11843248-Aged, 80 and over, pubmed-meshheading:11843248-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:11843248-Carcinoma, Endometrioid, pubmed-meshheading:11843248-Cisplatin, pubmed-meshheading:11843248-Cystadenocarcinoma, Serous, pubmed-meshheading:11843248-Etoposide, pubmed-meshheading:11843248-Female, pubmed-meshheading:11843248-Hematologic Diseases, pubmed-meshheading:11843248-Humans, pubmed-meshheading:11843248-Middle Aged, pubmed-meshheading:11843248-Neoplasm Recurrence, Local, pubmed-meshheading:11843248-Ovarian Neoplasms, pubmed-meshheading:11843248-Prognosis, pubmed-meshheading:11843248-Survival Rate, pubmed-meshheading:11843248-Treatment Outcome
pubmed:year	2001
pubmed:articleTitle	Weekly cisplatin and oral etoposide as treatment for relapsed epithelial ovarian cancer.
pubmed:affiliation	Department of Medical Oncology, Mount Vernon Hospital, Northwood, UK.
pubmed:publicationType	Journal Article